COYA vs TECH · rev $3.6M vs P/E 65, rev $1.22B
Coya Therapeutics, Inc. Common Stock (COYA) versus Bio-Techne Corp (TECH) — a side-by-side from cached financials, not a winner call.
Coya Therapeutics, Inc. Common Stock (COYA) is a biotechnology company listed on NASDAQ.
Bio-Techne Corp (TECH) is a biotechnology company listed on US.
Latest reported COYA revenue for 2024-12-31 was $3.6M. Net income was -$14.9M. Revenue was down 40.8% from 2023-12-31 to 2024-12-31. COYA currently screens at market cap $118.0M.
Latest reported TECH revenue for 2025-06-30 was $1.22B. Net income was $73.4M. Revenue was up 5.2% from 2024-06-30 to 2025-06-30. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
COYA currently screens at market cap $118.0M. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
Not investment advice. Open the COYA and TECH stock pages for the full models.
Not investment advice.